ReviewAnnals of African medicine2026
Evaluating the Efficacy of Ozone Therapy in Fibromyalgia.
Review in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractFibromyalgia is a chronic disorder, characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and psychological distress, with limited efficacy from conventional treatments. Ozone therapy, a medical approach that induces controlled oxidative stress to enhance antioxidant defences and modulate immune responses, has emerged as a potential complementary intervention. Evidence suggests that ozone therapy improves pain, fatigue, and sleep quality by correcting oxidative imbalances, enhancing oxygen utilization, and regulating inflammatory pathways. Clinical studies, report significant symptom relief in up to 70% of patients, with minimal adverse effects when administered according to standardized protocols. Despite promising outcomes, the current literature is constrained by small sample sizes, heterogeneity in study designs, and limited long-term follow-up data. Future research should focus on large-scale, well-designed trials, standardized treatment protocols, and mechanistic studies to establish ozone therapy's role in fibromyalgia management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.